Dr. Reddy's Laboratories
Dr. Reddy's Laboratories is an Indian multinational company based in Hyberabad,Telangana,India.
|Dr. Reddy's Laboratories|
|Type||Public / Private|
|Slogan||Good Health Can't Wait|
|Key people||Dr. K. Anji Reddy|
Scientist, philanthropist and entrepreneur, Dr. K Anji Reddy's passion for drug discovery and his pioneering contributions to making medicines affordable are legendary.
Born in Tadepalli in the Guntur district of Andhra Pradesh, India, in a well to do farming family, he grew up watching his father make herbal pills that he distributed free. Little did he realize the prophetic significance of what he saw.
The seeds of his lifelong passion for pharmaceuticals were sown when he was pursuing a BSc Tech degree at the University Department of Chemical Technology, Mumbai. He went on to secure a Doctorate in Chemical Engineering, subsequently, from the National Chemical Laboratory, Pune. He then worked for six years at the state owned Indian Drugs and Pharmaceuticals Limited, where his entrepreneurial ambitions were fired. In 1973, he left IDPL and over the next ten years was part of the founding team of two bulk drug manufacturing ventures.
Dr. Reddy's originally launched in 1984 producing active pharmaceutical ingredients. In 1986, Reddy's started operations on branded formulations. Within a year Reddy's had launched Norilet, the company's first recognized brand in India. Soon, Dr. Reddy's obtained another success with Omez, its branded omeprazole – ulcer and reflux oesophagitis medication – launched at half the price of other brands on the Indian market at that time. This is now branched in hyderabad.
From the beginning, Dr. Anji Reddy realized that if medicines had to serve their purpose they first had to be affordable and accessible. In fact, as early as 1973, he had written down his vision: 'to bring new molecules into the country at a price the common man can afford'. Even as he built a global pharmaceutical conglomerate, Dr. Anji Reddy ensured that he shared his success with those who were less fortunate. He did not see the larger purpose of his pharmaceutical business as being very different from that of the social enterprises that he set up. Among several initiatives, he set up the Livelihood Advancement Business School (LABS) to help young people from disadvantaged backgrounds to learn skills, secure gainful employment and become contributing members of society.
Within a year, Reddy's became the first Indian company to export the active ingredients for pharmaceuticals to Europe. In 1987, Reddy's started to transform itself from a supplier of pharmaceutical ingredients to other manufacturers into a manufacturer of pharmaceutical products.
Till the end Dr. Reddy remained true to his passion for drug discovery, even to the extent of setting up a separate company using his personal funds. It was not only the compulsion of the innovator that drove him, but also his conviction that medicines to be useful must be affordable. He referred to this as his "unfinished agenda."
As a company that was started by a scientist, Dr Reddy’s fosters a culture where scientific temperament is rooted in our people and our approach to research. Our research efforts are geared toward accelerating access to affordable and innovative medicines. We focus our work on being first to market with products that are difficult to make. Why? These tough-to-make products are likely to be very expensive, and our unique capabilities allow us to improve accessibility to them. Similarly, our patient-centric approach means we tend to focus on developing differentiated products that best address unmet patient needs.
At the heart of our research and development organization is our state-of-the-art R&D Center spread over 300,000 sq. ft. The Center houses over 70 laboratories and has over 800 research scientists working on various projects. This R&D Center works in close conjunction with other centers across the UK and the Netherlands.
Work at the R&D Center results in a wide-ranging suite of capabilities and services—from synthetic organic chemistry to formulations development; from intellectual property management to regulatory science; from polymorphism to bio-pharmaceutics. For our industry customers, we’re able to offer services and solutions for starting material, intermediates, active ingredients and finished-dosage forms.
The success of our research organization can be judged by the fact that we have over 170 ANDAs, over 500 DMFs and 86 patents filed in the last five years.
- Dr. Reddy's recalls drugs that failed impurities test 
- Dr Reddy’s sued for infringement of thyroid injection patent 
- Consumer safety agency says Indian company sold improperly packaged drugs 
Oncology Gastroenterology Cardiovascular Anti-Diabetic Dermatology Pain Management
Top 5 Recent News Headlines
Top 5 Lifetime Tweets
|16 Jan, 2018||@drreddys||Ever wondered what your eyes say about your health? Take the test to find out|
|9 Jan, 2018||@drreddys||Today, we commemorate #HarGobindKhorana, whose research in biochemistry, along with Marshall W. Nirenberg and Robert W. Holley showed us how the order of nucleotides in nucleic acids, control the cell’s synthesis of proteins.|
|9 Jan, 2018||@drreddys||We are proud to announce that Dr. Reddy’s will present at #JPM18, the largest healthcare investment symposium in the industry. Alok Sonig will speak in San Francisco on Tuesday, January 9, 2018, at 2 pm (PT). Presentation material will be available at http://www.drreddys.com|
Ever wondered what your eyes say about your health? Take the test to find out.Dr.Reddy's added,
True or false: Doctors can tell if you have high cholesterol by looking at your eyes. http://wb.md/2mDWxID
Top 5 Lifetime News Headlines
- ↑ http://www.fiercepharma.com/manufacturing/dr-reddy-s-recalls-drugs-failed-impurities-test
- ↑ http://www.thehindu.com/business/Industry/dr-reddys-sued-for-infringement-of-thyroid-injection-patent/article4829453.ece
- ↑ https://www.statnews.com/pharmalot/2016/06/09/dr-reddys-packaging-doj-civil-penalties/